Healthcare -
Biotechnology - NASDAQ - US
$ 3.35
0.601 %
$ 2.33 M
Market Cap
0.0
P/E
RNAZ - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative RNAZ - TransCode Therapeutics, Inc.
6.64 M
LAST VALUE
39.79%
2 YEAR CAGR
85.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR